Detalhe da pesquisa
1.
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022.
Ann Oncol
; 34(1): 48-60, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36182023
2.
HER2-low expression in patients with advanced or metastatic solid tumors.
Ann Oncol
; 34(11): 1035-1046, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37619847
3.
Defining the subset of mutations in Polymerase Epsilon (POLE) associated with Loss-of-Proofreading (LOP) functionality.
Ann Oncol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734075
4.
Phase I trial outcomes in older patients with advanced solid tumours.
Br J Cancer
; 114(3): 262-8, 2016 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26757260
5.
Complications of hyperglycaemia with PI3K-AKT-mTOR inhibitors in patients with advanced solid tumours on Phase I clinical trials.
Br J Cancer
; 113(11): 1541-7, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26554652
6.
Patient selection biomarker strategies for PARP inhibitor therapy.
Ann Oncol
; 31(12): 1603-1605, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33011228
7.
Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail.
Br J Cancer
; 111(5): 828-36, 2014 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24983367
8.
Targeting gamma secretase: has progress moved up a Notch?
Ann Oncol
; 29(9): 1889-1891, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30084907
9.
First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours.
Br J Cancer
; 106(8): 1379-85, 2012 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491421
10.
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies.
Ann Oncol
; 23(5): 1307-1313, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22015452
11.
The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trials.
Eur J Gynaecol Oncol
; 33(2): 211-3, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22611966
12.
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study.
Br J Cancer
; 103(3): 332-9, 2010 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20628389
13.
Challenges in combining novel molecularly targeted agents in cancer medicine.
Ann Oncol
; 26(1): 9-11, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336115
14.
Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancer.
Ann Oncol
; 24(5): 1416-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23524863
15.
Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer.
Eur J Cancer
; 59: 65-78, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27016624